The White House called out prominent Democrats for allegedly failing to deliver on promises to lower prescription drug prices, accusing them of protecting a system that favors pharmaceutical companies ...

Emily Field, head of European pharmaceutical research at Barclays, says U.S. President Donald Trump's executive order on drug pricing marks the start of negotiations with pharmaceutical companies.

Representative Maria Elvira Salazar (R-FL) said she was "delighted" by President Donald Trump's executive order to lower ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

We are going to pay the lowest price there is in the world,” Trump said before signing the executive order, which was met with skepticism.

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations ...

McDermott was pleased to once again host our annual European Health & Life Sciences Symposium in Paris. Welcoming a crowd of more than ...

The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets ...

President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...

The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...